Início › Melanoma › Califórnia

Ensaios clínicos de Melanoma em Califórnia

70 estudos para Melanoma estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
e mais 20

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

UCSF Medical Center at Mission Bay ( Site 4044), San Francisco

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06961006

DESTINY-PANTUMOUR04

Research Site, San Diego

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Tower Cancer Research Foundation, Beverly Hills
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
e mais 4

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Providence Medical Foundation, Fullerton
Cancer and Blood Specialty Clinic, Los Alamitos
University of California Los Angeles, Los Angeles
e mais 6

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

City of Hope, Duarte
USC Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Kaiser Permanente-Oakland, Oakland

RecrutandoFase 2

Até 25 anos · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07621614

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

Pan-tumor MRD Study

Los Angeles Cancer Network (LACN), Glendale
Ventura County Hematology Oncology Specialists, Oxnard
Medical Oncology Associates of San Diego (MOASD), San Diego
e mais 2

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
e mais 14

RecrutandoFase 3

Idades 75 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07068074

Intratumoral N17350 in Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles
UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Scripps Clinic Torrey Pines - La Jolla, San Diego
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07339176

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

City of Hope National Medical Center, Duarte

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT04752826

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0096, San Francisco

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
Epic Care-Dublin, Dublin
Bay Area Breast Surgeons Inc, Emeryville
e mais 9

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

City of Hope, Duarte

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

University of California-San Diego, La Jolla
START Los Angeles, Los Angeles
University of California-San Fransisco, San Francisco

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07287917

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

The Angeles Clinic, Los Angeles
UCLA, Los Angeles
University of California San Diego, Moores Cancer Center, San Diego
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT04913285

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco, San Francisco

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07070232

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT05830058

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

UC San Diego Moores Cancer Center, La Jolla
Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital Los Angeles, Los Angeles
Children's Hospital of Orange County, Orange
UCSF Medical Center-Mission Bay, San Francisco

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Kaiser Permanente Downey Medical Center, Downey
City of Hope Comprehensive Cancer Center, Duarte
Loma Linda University Medical Center, Loma Linda
e mais 15

RecrutandoEstudo observacional

Até 25 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT02402244

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

UC San Diego Moores Cancer Center, La Jolla
University of California, San Francisco, San Francisco

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT04598009

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04895709

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Comprehensive Blood and Cancer Center, Bakersfield
Providence Medical Foundation, Fullerton
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06425926

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

START Los Angeles, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06880549

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Los Angeles Cancer Network, Los Angeles
Pih Health Hematology Medical Oncology, Whittier

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

RecrutandoFase 1 inicial

Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT07628634

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
California Research Institute, Los Angeles
e mais 3

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

The Angeles Clinic and Research Institute (Melanoma), Los Angeles
USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles
Stanford Cancer Institute (Melanoma/NSCLC), Stanford

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06060613

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT06580002

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

KP Southern California - Department of Research & Evaluation, Pasadena

Recrutando

Idades de 21 a 45 · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT07406087

The Multicentre Selective Lymphadenectomy Trial - 3

Cedars-Sinai Medical Centre, Los Angeles

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT07049276

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

The Angeles Clinic and Research Institute, Los Angeles

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05361174

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

University of California Irvine, Orange

RecrutandoFase 1/2

Idades de 18 a 90 · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT05655312

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

UCLA Medical Center, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT03947385

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA06-0, Los Angeles
USA16-0, Los Angeles

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT06953089

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.